Viewing StudyNCT00315211



Ignite Creation Date: 2024-05-05 @ 4:46 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00315211
Status: TERMINATED
Last Update Posted: 2018-08-20
First Post: 2006-04-17

Brief Title: Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Sponsor: Aultman Health Foundation
Organization: Aultman Health Foundation

Organization Data

Organization: Aultman Health Foundation
Class: OTHER
Study ID: Hycamtin study 102143
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Aultman Health Foundation
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
GlaxoSmithKline INDUSTRY